10 newer rulings cite the same tariff codes.
Classification can shift over time. Review the more recent rulings below before relying on this one.
The tariff classification of Tazarotene (CAS-118292-40-3) in bulk form, from Finland
Issued May 19, 2011 by U.S. Customs and Border Protection.
Cite this ruling
Copies to clipboardN1 N163667 (May 19, 2011)
Tariff classification
HTS codes: 2934.99.3000
Headings: 2934
Product description
The subject product, Tazarotene, is a member of the acetylenic class of retinoids. It is indicated for the topical treatment of patients with stable plaque psoriasis of up to 20% body surface area involvement. It is also indicated for the treatment of facial acne vulgaris of mild to moderate severity.
CBP rationale
The applicable subheading for the Tazarotene in bulk form will be 2934.99.3000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: Other: Other: Aromatic or modified aromatic: Other: Drugs.
Full text
N163667 May 19, 2011 CLA-2-29:OT:RR:NC:N2:238 CATEGORY: Classification TARIFF NO.: 2934.99.3000 Ms. Robyn Addabbo InterChem Corporation 120 Route 17 North P.O. Box 1579 Paramus, NJ 07652-1579 RE: The tariff classification of Tazarotene (CAS-118292-40-3) in bulk form, from Finland Dear Ms. Addabbo: In your letter dated April 27, 2011, you requested a tariff classification ruling. The subject product, Tazarotene, is a member of the acetylenic class of retinoids. It is indicated for the topical treatment of patients with stable plaque psoriasis of up to 20% body surface area involvement. It is also indicated for the treatment of facial acne vulgaris of mild to moderate severity. The applicable subheading for the Tazarotene in bulk form will be 2934.99.3000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: Other: Other: Aromatic or modified aromatic: Other: Drugs.” Pursuant to General Note 13, HTSUS, the rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at (646) 733-3033. Sincerely, Robert B. Swierupski Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Elinzanetant (CAS No. 929046-33-3) in bulk form and LYNKUET® (E linzanetant) Capsules in dosage form, from Germany
The tariff classification of Terazosin Hydrochloride Anhydrous (CAS No. 63074-08-8) in bulk form, from Germany
The tariff classification of Cabotegravir (CAS No. 1051375-10-0) in bulk powder form, from Brazil
The tariff classification of Ozanimod (CAS No. 1306760-87-1) in bulk form, from Taiwan
The tariff classification of Cabotegravir (CAS No. 1051375-10-0) in bulk powder form, from Brazil
The tariff classification of Aprepitant (CAS No. 170729-80-3) in bulk powder form, from Spain
The tariff classification of Brexpiprazole (CAS No. 913611-97-9) in bulk power form, from Taiwan
The tariff classification of Rivaroxaban (CAS No. 366789-02-8) in bulk powder form, from Mexico
The tariff classification of Prucalopride Succinate (CAS No. 179474-85-2) in bulk form, from India
The tariff classification of Ozanimod Hydrochloride (CAS No. 1618636-37-5), Brivaracetam (CAS No. 357336-20-0) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk form, from Taiwan
Follow N163667
Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.
One email per day at most. Confirm your address once, unsubscribe anytime.
Searching CBP rulings the smart way
Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.